Detalhe da pesquisa
1.
MIR29B regulates expression of MLLT11 (AF1Q), an MLL fusion partner, and low MIR29B expression associates with adverse cytogenetics and poor overall survival in AML.
Br J Haematol
; 153(6): 753-7, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21496004